Showing results (51-60 of 108) with videos related to
Sort By:
Pageof 11
Bone Marrow Transplantation|May 30, 1998
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV diseaseD Gor, C Sabin, H G Prentice, et al.Journal of Medical Virology|May 21, 1999
Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG)A F Hassan-Walker, I M Kidd, C Sabin, et al.Gut|January 23, 1999
Single portal pressure measurement predicts survival in cirrhotic patients with recent bleedingD Patch, A Armonis, C Sabin, et al.BMJ Open|April 22, 2018
Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative studyTessa van Middelaar, Sophie D Ivens, Petra G van Peet, et al.Journal of Viral Hepatitis|December 15, 2017
Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antiviralsR Simmons, G Ireland, W Irving, et al.Clinical and Experimental Immunology|November 25, 2000
The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczemaC H Orteu, M H Rustin, E O'Toole, et al.Alimentary Pharmacology & Therapeutics|July 11, 2006
Nutritional status and prognosis in cirrhotic patientsF Gunsar, M L Raimondo, S Jones, et al.HIV Medicine|July 28, 2018
Prevalence of diagnosed HIV infection among persons with hepatitis C virus infection: England, 2008-2014G Ireland, V Delpech, P Kirwan, et al.HIV Medicine|March 15, 2012
Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuriaA Samarawickrama, M Cai, E R Smith, et al.The Journal of Infectious Diseases|January 7, 1998
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupP D Griffiths, J E Feinberg, J Fry, et al.Pageof 11